Concepedia

Isabell Bernlochner

IB

Statistics

Publications

46

Citations

3.3K

H-Index

27

Active since

2005

Affiliations

TUM Klinikum(Current)

Deutsches Herzzentrum München

German Centre for Cardiovascular Research

Technical University of Munich

Ludwig-Maximilians-Universität München

Isabell Bernlochner is an author at TUM Klinikum specializing in medicine, cardiology, and thrombosis.

ORCID

Publications per year

2005–2024

46

Publications

46

Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes

Stefanie Schüpke, Franz‐Josef Neumann, Maurizio Menichelli et al. · New England Journal of Medicine · 2019 · 789 citations · Full text

, , +17

ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting

Stefanie Schüpke, Robert A. Byrne, Jurriën M. ten Berg et al. · European Heart Journal · 2015 · 429 citations · Full text

, , +17

No association of paraoxonase-1 Q192R genotypes with platelet response to clopidogrel and risk of stent thrombosis after coronary stenting

Dirk Sibbing, W. Koch, Robert A. Byrne et al. · European Heart Journal · 2011 · 186 citations · Full text

, , +17

A 2-Step Mechanism of Arterial Thrombus Formation Induced by Human Atherosclerotic Plaques

Armin J. Reininger, Isabell Bernlochner, Sandra Penz et al. · Journal of the American College of Cardiology · 2010 · 184 citations

, , +16

Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI

Sandra Penz, Armin J. Reininger, Richard Brandl et al. · The FASEB Journal · 2005 · 162 citations

, , +17

1–5 of 46